Literature DB >> 9771475

The erbB/HER type 1 tyrosine kinase receptor family.

R A Walker.   

Abstract

The erb type 1 tyrosine kinase receptors are important for mediating proliferation and differentiation, and aberrant activation may contribute to tumour development and progression. They comprise epidermal growth factor receptor (EGFR), c-erbB-2, c-erbB-3, and c-erbB-4. There are overlaps and differences in the cellular distribution of the four receptors, which is of significance since they can form heterodimers that give differing responses to different ligands. The different distributions could be of particular importance in cancer if therapeutic modalities are identified to inhibit or stimulate the different ligands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771475     DOI: 10.1002/(SICI)1096-9896(199807)185:3<234::AID-PATH128>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

Review 1.  Pulmonary epithelial barrier function: some new players and mechanisms.

Authors:  Kieran Brune; James Frank; Andreas Schwingshackl; James Finigan; Venkataramana K Sidhaye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-30       Impact factor: 5.464

2.  Urothelial carcinomas: a focus on human epidermal receptors signaling.

Authors:  Petros D Grivas; Mark Day; Maha Hussain
Journal:  Am J Transl Res       Date:  2011-07-25       Impact factor: 4.060

3.  Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.

Authors:  Ana M Bajo; Andrew V Schally; Magdalena Krupa; Francine Hebert; Kate Groot; Karoly Szepeshazi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

4.  The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma.

Authors:  Abbas Ghaderi; Mohammad Vasei; S A Maleck-Hosseini; Behronz Gharesi-Fard; Maliheh Khodami; Mehrnoosh Doroudchi; Helmout Modjtahedi
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

5.  Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.

Authors:  Daoqiang Tang; Charles Yj Liu; Danping Shen; Shuqiong Fan; Xinying Su; Peng Ye; Paul R Gavine; Xiaolu Yin
Journal:  Onco Targets Ther       Date:  2014-12-16       Impact factor: 4.147

Review 6.  A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.

Authors:  Mohammed I El-Gamal; Nada H Mewafi; Nada E Abdelmotteleb; Minnatullah A Emara; Hamadeh Tarazi; Rawan M Sbenati; Moustafa M Madkour; Seyed-Omar Zaraei; Afnan I Shahin; Hanan S Anbar
Journal:  Molecules       Date:  2021-12-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.